Obesity Facts

Papers
(The H4-Index of Obesity Facts is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Definition and Diagnostic Criteria for Sarcopenic Obesity: ESPEN and EASO Consensus Statement212
European Guidelines for Obesity Management in Adults with a Very Low-Calorie Ketogenic Diet: A Systematic Review and Meta-Analysis115
Physical Activity, Screen Time, and Sleep Duration of Children Aged 6–9 Years in 25 Countries: An Analysis within the WHO European Childhood Obesity Surveillance Initiative (COSI) 2015–201763
Malnutrition in Obesity: Is It Possible?43
Prevalence of Micronutrient Deficiency after Bariatric Surgery28
Prevalence of Childhood Obesity in the United States in 1999–2018: A 20-Year Analysis27
Prevalence and Correlates of Overweight and Obesity in 12 European Countries in 2017–201827
COVID-19 and Obesity: Overlapping of Two Pandemics23
The Role of Sleep Curtailment on Leptin Levels in Obesity and Diabetes Mellitus23
Parental Perceptions of Children’s Weight Status in 22 Countries: The WHO European Childhood Obesity Surveillance Initiative: COSI 2015/201722
The Effect of Body Weight and Alcohol Consumption on Hyperuricemia and Their Population Attributable Fractions: A National Health Survey in China21
Autism Spectrum Disorder and Obesity in Children: A Systematic Review and Meta-Analysis20
Rapid Emergence of Appetite and Hunger Resulting in Weight Gain and Improvement of Eating Disorder Symptomatology during and after Short-Term Off-Label Metreleptin Treatment of a Patient with Anorexia20
The Global Spread of Severe Obesity in Toddlers, Children, and Adolescents: A Systematic Review and Meta-Analysis19
European Association for the Study of Obesity Position Statement on Medical Nutrition Therapy for the Management of Overweight and Obesity in Adults Developed in Collaboration with the European Federa18
Liraglutide for Weight Management in the Real World: Significant Weight Loss Even if the Maximal Daily Dose Is Not Achieved18
Canagliflozin: A New Therapeutic Option in Patients That Present Postprandial Hyperinsulinemic Hypoglycemia after Roux-en-Y Gastric Bypass: A Pilot Study17
0.29432916641235